{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:26:51Z","timestamp":1794536811397,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["LIDER\/4\/0099\/L-7\/15\/NCBR\/2016"],"award-info":[{"award-number":["LIDER\/4\/0099\/L-7\/15\/NCBR\/2016"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Agency in Poland","award":["2020\/ABM\/SARS\/1"],"award-info":[{"award-number":["2020\/ABM\/SARS\/1"]}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2020\/01\/0\/NZ1\/00063"],"award-info":[{"award-number":["UMO-2020\/01\/0\/NZ1\/00063"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","award":["TEAM\/2017-4\/32"],"award-info":[{"award-number":["TEAM\/2017-4\/32"]}],"id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Essential oils and aromatic extracts (oleoresins, absolutes, concretes, resinoids) are often used as food flavorings and constituents of fragrance compositions. The flavor and fragrance industry observed significant growth in the sales of some natural materials during the COVID-19 outbreak. Some companies worldwide are making false claims regarding the effectiveness of their essential oils or blends (or indirectly point toward this conclusion) against coronaviruses, even though the available data on the activity of plant materials against highly pathogenic human coronaviruses are very scarce. Our exploratory study aimed to develop pioneering knowledge and provide the first experimental results on the inhibitory properties of hundreds of flavor and fragrance materials against SARS-CoV-2 main and papain-like proteases and the antiviral potential of the most active protease inhibitors. As essential oils are volatile products, they could provide an interesting therapeutic strategy for subsidiary inhalation in the long term.<\/jats:p>","DOI":"10.1038\/s41598-022-18676-w","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T16:02:49Z","timestamp":1661011369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts"],"prefix":"10.1038","volume":"12","author":[{"given":"Daniel Jan","family":"Strub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Talma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Strub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioletta","family":"Rut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikolaj","family":"Zmudzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W\u0142adys\u0142aw","family":"Brud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vangeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuanyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digant","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun K.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Hilgenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Dr\u0105g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"key":"18676_CR1","doi-asserted-by":"crossref","unstructured":"Baser, K. H. C. & Buchbauer, G. Handbook of Essential Oils: Science, Technology, and Applications, Second Edition. (CRC Press, 2015).","DOI":"10.1201\/b19393"},{"key":"18676_CR2","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41598-020-59332-5","volume":"10","author":"AF Feyaerts","year":"2020","unstructured":"Feyaerts, A. F., Luyten, W. & Van Dijck, P. Striking essential oil: tapping into a largely unexplored source for drug discovery. Sci. Rep. 10, 2867. https:\/\/doi.org\/10.1038\/s41598-020-59332-5 (2020).","journal-title":"Sci. Rep."},{"key":"18676_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0166-3542(00)00127-3","volume":"48","author":"A De Logu","year":"2000","unstructured":"De Logu, A., Loy, G., Pellerano, M. L., Bonsignore, L. & Schivo, M. L. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res. 48, 177\u2013185. https:\/\/doi.org\/10.1016\/S0166-3542(00)00127-3 (2000).","journal-title":"Antiviral Res."},{"key":"18676_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/03079457.2011.605107","volume":"40","author":"J Yin","year":"2011","unstructured":"Yin, J., Li, G., Li, J., Yang, Q. & Ren, X. In vitro and in vivo effects of Houttuynia cordata on infectious bronchitis virus. Avian Pathol. 40, 491\u2013498. https:\/\/doi.org\/10.1080\/03079457.2011.605107 (2011).","journal-title":"Avian Pathol."},{"key":"18676_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41392-020-0190-2","volume":"5","author":"B Chen","year":"2020","unstructured":"Chen, B. et al. Overview of lethal human coronaviruses. Signal Transduct. Target. Ther. 5, 89. https:\/\/doi.org\/10.1038\/s41392-020-0190-2 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"18676_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536\u2013544. https:\/\/doi.org\/10.1038\/s41564-020-0695-z (2020).","journal-title":"Nat. Microbiol."},{"key":"18676_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173890","volume":"895","author":"P Tarighi","year":"2021","unstructured":"Tarighi, P. et al. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment. Eur. J. Pharmacol. 895, 173890. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173890 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"18676_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science 368, 409\u2013412. https:\/\/doi.org\/10.1126\/science.abb3405 (2020).","journal-title":"Science"},{"key":"18676_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","volume":"587","author":"D Shin","year":"2020","unstructured":"Shin, D. et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587, 657\u2013662. https:\/\/doi.org\/10.1038\/s41586-020-2601-5 (2020).","journal-title":"Nature"},{"key":"18676_CR10","doi-asserted-by":"publisher","first-page":"eabd4596","DOI":"10.1126\/sciadv.abd4596","volume":"6","author":"W Rut","year":"2020","unstructured":"Rut, W. et al. Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti\u2013COVID-19 drug design. Sci. Adv. 6, eabd4596. https:\/\/doi.org\/10.1126\/sciadv.abd4596 (2020).","journal-title":"Sci. Adv."},{"key":"18676_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y (2020).","journal-title":"Nature"},{"key":"18676_CR12","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1021\/acs.jmedchem.1c00509","volume":"65","author":"N Kitamura","year":"2022","unstructured":"Kitamura, N. et al. Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors. J. Med. Chem. 65, 2848\u20132865. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00509 (2022).","journal-title":"J. Med. Chem."},{"key":"18676_CR13","doi-asserted-by":"publisher","first-page":"20697","DOI":"10.1021\/jacs.1c08060","volume":"143","author":"C Ma","year":"2021","unstructured":"Ma, C. et al. Discovery of Di- and trihaloacetamides as covalent SARS-CoV-2 main protease inhibitors with high target specificity. J. Am. Chem. Soc. 143, 20697\u201320709. https:\/\/doi.org\/10.1021\/jacs.1c08060 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"18676_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.abb4489","volume":"368","author":"W Dai","year":"2020","unstructured":"Dai, W. et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368, 1331\u20131335. https:\/\/doi.org\/10.1126\/science.abb4489 (2020).","journal-title":"Science"},{"key":"18676_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41564-022-01119-7","volume":"7","author":"B-X Quan","year":"2022","unstructured":"Quan, B.-X. et al. An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron. Nat. Microbiol. 7, 716\u2013725. https:\/\/doi.org\/10.1038\/s41564-022-01119-7 (2022).","journal-title":"Nat. Microbiol."},{"key":"18676_CR16","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1021\/acsptsci.0c00108","volume":"3","author":"W Zhu","year":"2020","unstructured":"Zhu, W. et al. Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening. ACS Pharmacol. Trans. Sci. 3, 1008\u20131016. https:\/\/doi.org\/10.1021\/acsptsci.0c00108 (2020).","journal-title":"ACS Pharmacol. Trans. Sci."},{"key":"18676_CR17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","volume":"7","author":"C Ma","year":"2021","unstructured":"Ma, C. et al. Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and a FlipGFP-based reporter assay. ACS Cent. Sci. 7, 1245\u20131260. https:\/\/doi.org\/10.1021\/acscentsci.1c00519 (2021).","journal-title":"ACS Cent. Sci."},{"key":"18676_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","volume":"30","author":"C Ma","year":"2020","unstructured":"Ma, C. et al. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Res. 30, 678\u2013692. https:\/\/doi.org\/10.1038\/s41422-020-0356-z (2020).","journal-title":"Cell Res."},{"key":"18676_CR19","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.chembiol.2021.05.018","volume":"28","author":"D Zaidman","year":"2021","unstructured":"Zaidman, D. et al. An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro<\/sup> inhibitor. Cell Chem. Biol. 28, 1795-1806.e1795. https:\/\/doi.org\/10.1016\/j.chembiol.2021.05.018 (2021).","journal-title":"Cell Chem. Biol."},{"key":"18676_CR20","doi-asserted-by":"publisher","first-page":"23450","DOI":"10.1039\/D1RA03956C","volume":"11","author":"JRA Silva","year":"2021","unstructured":"Silva, J. R. A., Kruger, H. G. & Molfetta, F. A. Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2. RSC Adv. 11, 23450\u201323458. https:\/\/doi.org\/10.1039\/D1RA03956C (2021).","journal-title":"RSC Adv."},{"key":"18676_CR21","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","volume":"65","author":"Y Unoh","year":"2022","unstructured":"Unoh, Y. et al. Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19. J. Med. Chem. 65, 6499\u20136512. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00117 (2022).","journal-title":"J. Med. Chem."},{"key":"18676_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1126\/science.abg5827","volume":"373","author":"N Drayman","year":"2021","unstructured":"Drayman, N. et al. Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science 373, 931\u2013936. https:\/\/doi.org\/10.1126\/science.abg5827 (2021).","journal-title":"Science"},{"key":"18676_CR23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024302118","volume":"118","author":"WD Jang","year":"2021","unstructured":"Jang, W. D., Jeon, S., Kim, S. & Lee, S. Y. Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay. Proc. Natl. Acad. Sci. 118, e2024302118. https:\/\/doi.org\/10.1073\/pnas.2024302118 (2021).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"18676_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.636989","author":"L Pinzi","year":"2021","unstructured":"Pinzi, L., Tinivella, A., Caporuscio, F. & Rastelli, G. Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.636989 (2021).","journal-title":"Front. Pharmacol."},{"key":"18676_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s42003-022-03090-9","volume":"5","author":"A Narayanan","year":"2022","unstructured":"Narayanan, A. et al. Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay. Commun. Biol. 5, 169. https:\/\/doi.org\/10.1038\/s42003-022-03090-9 (2022).","journal-title":"Commun. Biol."},{"key":"18676_CR26","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen, D. R. et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science 374, 1586\u20131593. https:\/\/doi.org\/10.1126\/science.abl4784 (2021).","journal-title":"Science"},{"key":"18676_CR27","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1021\/acsinfecdis.0c00168","volume":"6","author":"BT Freitas","year":"2020","unstructured":"Freitas, B. T. et al. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease. ACS Infect. Dis. 6, 2099\u20132109. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00168 (2020).","journal-title":"ACS Infect. Dis."},{"key":"18676_CR28","doi-asserted-by":"publisher","first-page":"e106275","DOI":"10.15252\/embj.2020106275","volume":"39","author":"T Klemm","year":"2020","unstructured":"Klemm, T. et al. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2. EMBO J. 39, e106275. https:\/\/doi.org\/10.15252\/embj.2020106275 (2020).","journal-title":"EMBO J."},{"key":"18676_CR29","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","volume":"65","author":"Z Shen","year":"2022","unstructured":"Shen, Z. et al. Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity. J. Med. Chem. 65, 2940\u20132955. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01307 (2022).","journal-title":"J. Med. Chem."},{"key":"18676_CR30","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1021\/acsinfecdis.0c00815","volume":"7","author":"K Steuten","year":"2021","unstructured":"Steuten, K. et al. Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19. ACS Infect. Dis. 7, 1457\u20131468. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00815 (2021).","journal-title":"ACS Infect. Dis."},{"key":"18676_CR31","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-997891\/v2","author":"D Strub","year":"2021","unstructured":"Strub, D. et al. Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts. PREPRINT (Version 2). Res. Square https:\/\/doi.org\/10.21203\/rs.3.rs-997891\/v2 (2021).","journal-title":"Res. Square"},{"key":"18676_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/biom10040659","volume":"10","author":"M Talma","year":"2020","unstructured":"Talma, M. & Mucha, A. P1\u2032 Residue-oriented virtual screening for potent and selective phosphinic (Dehydro) dipeptide inhibitors of metallo-aminopeptidases. Biomolecules 10, 659. https:\/\/doi.org\/10.3390\/biom10040659 (2020).","journal-title":"Biomolecules"},{"key":"18676_CR33","doi-asserted-by":"publisher","first-page":"eabe0751","DOI":"10.1126\/sciadv.abe0751","volume":"6","author":"MD Sacco","year":"2020","unstructured":"Sacco, M. D. et al. Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L. Sci. Adv. 6, eabe0751. https:\/\/doi.org\/10.1126\/sciadv.abe0751 (2020).","journal-title":"Sci. Adv."},{"key":"18676_CR34","unstructured":"Schr\u00f6dinger, L.L.C. Schr\u00f6dinger Release 2020-1: Schr\u00f6dinger Suite 2020-1 Protein Preparation Wizard; Epik: New York, NY, USA, (2020)."},{"key":"18676_CR35","unstructured":"Schr\u00f6dinger LLC. Schr\u00f6dinger Release 2020-1: LigPrep; Schr\u00f6dinger LLC: New York, NY, USA, (2020)."},{"key":"18676_CR36","unstructured":"Schr\u00f6dinger Release 2020-1: Induced Fit; Docking Protocol; Induced Fit Docking protocol; Glide, Schr\u00f6dinger,LLC: New York, NY, USA, (2020)."},{"key":"18676_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-020-00689-z","author":"W Rut","year":"2020","unstructured":"Rut, W. et al. SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nat. Chem. Biol. https:\/\/doi.org\/10.1038\/s41589-020-00689-z (2020).","journal-title":"Nat. Chem. Biol."},{"key":"18676_CR38","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/ph14080742","volume":"14","author":"I Nawrot-Hadzik","year":"2021","unstructured":"Nawrot-Hadzik, I. et al. Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study. Pharmaceuticals 14, 742 (2021).","journal-title":"Pharmaceuticals"},{"key":"18676_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jviromet.2012.04.011","volume":"183","author":"D Jochmans","year":"2012","unstructured":"Jochmans, D., Leyssen, P. & Neyts, J. A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. J. Virol. Methods 183, 176\u2013179. https:\/\/doi.org\/10.1016\/j.jviromet.2012.04.011 (2012).","journal-title":"J. Virol. Methods"},{"key":"18676_CR40","unstructured":"Albert Vieille SAS catalogue, Cistus ladaniferus, Vallauris. (2017)."},{"key":"18676_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bse.2003.09.010","volume":"32","author":"H Merle","year":"2004","unstructured":"Merle, H., Mor\u00f3n, M., Bl\u00e1zquez, M. A. & Boira, H. Taxonomical contribution of essential oils in mandarins cultivars. Biochem. Syst. Ecol. 32, 491\u2013497. https:\/\/doi.org\/10.1016\/j.bse.2003.09.010 (2004).","journal-title":"Biochem. Syst. Ecol."},{"key":"18676_CR42","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/ffj.1640","volume":"21","author":"MA Apel","year":"2006","unstructured":"Apel, M. A., Sobral, M., Zuanazzi, J. \u00c2. S. & Henriques, A. T. Essential oil composition of Calycorectes australis and Calycorectes psidii\u00dforus (Myrtaceae). Flavour Fragr. J. 21, 656\u2013658. https:\/\/doi.org\/10.1002\/ffj.1640 (2006).","journal-title":"Flavour Fragr. J."},{"key":"18676_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ffj.1189","volume":"18","author":"A Rotman","year":"2003","unstructured":"Rotman, A. et al. Aromatic plants from Yungas. Part III. Composition and antimicrobial activity of Myrrhinium atropurpureum Schott var. octandrum Bentham essential oil. Flavour Fragr. J. 18, 211\u2013214. https:\/\/doi.org\/10.1002\/ffj.1189 (2003).","journal-title":"Flavour Fragr. J."},{"key":"18676_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ffj.1113","volume":"17","author":"RP Limberger","year":"2002","unstructured":"Limberger, R. P. et al. Essential oils from some Myrceugenia species (Myrtaceae). Flavour Fragr. J. 17, 341\u2013344. https:\/\/doi.org\/10.1002\/ffj.1113 (2002).","journal-title":"Flavour Fragr. J."},{"key":"18676_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ffj.1032","volume":"17","author":"MDGB Zoghbi","year":"2002","unstructured":"Zoghbi, M. D. G. B., Andrade, E. H. A., da Silva, M. H. L. & Maia, J. G. S. Volatile constituents of Lippia lupulina Cham. Flavour Fragr. J. 17, 29\u201331. https:\/\/doi.org\/10.1002\/ffj.1032 (2002).","journal-title":"Flavour Fragr. J."},{"key":"18676_CR46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ffj.1878","volume":"23","author":"M Lo Presti","year":"2008","unstructured":"Lo Presti, M. et al. Evaluation of the volatile and chiral composition in Pistacia lentiscus L essential oil. Flavour Fragr. J. 23, 249\u2013257. https:\/\/doi.org\/10.1002\/ffj.1878 (2008).","journal-title":"Flavour Fragr. J."},{"key":"18676_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jep.2008.03.018","volume":"118","author":"K-M Lau","year":"2008","unstructured":"Lau, K.-M. et al. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J. Ethnopharmacol. 118, 79\u201385. https:\/\/doi.org\/10.1016\/j.jep.2008.03.018 (2008).","journal-title":"J. Ethnopharmacol."},{"key":"18676_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/14756366.2012.753591","volume":"29","author":"DW Kim","year":"2014","unstructured":"Kim, D. W. et al. Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J. Enzyme Inhib. Med. Chem. 29, 59\u201363. https:\/\/doi.org\/10.3109\/14756366.2012.753591 (2014).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"18676_CR49","first-page":"124","volume":"3","author":"W Luo","year":"2009","unstructured":"Luo, W. et al. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci. Trends 3, 124\u2013126 (2009).","journal-title":"Biosci. Trends"},{"key":"18676_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/ecam\/neh081","volume":"2","author":"C-N Chen","year":"2005","unstructured":"Chen, C.-N. et al. Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3\u2019-digallate (TF3). Evid. Based Complement. Altern. Med. 2, 209\u2013215. https:\/\/doi.org\/10.1093\/ecam\/neh081 (2005).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"18676_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.antiviral.2009.02.001","volume":"82","author":"M Zhuang","year":"2009","unstructured":"Zhuang, M. et al. Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res. 82, 73\u201381. https:\/\/doi.org\/10.1016\/j.antiviral.2009.02.001 (2009).","journal-title":"Antiviral Res."},{"key":"18676_CR52","doi-asserted-by":"publisher","first-page":"11334","DOI":"10.1128\/JVI.78.20.11334-11339.2004","volume":"78","author":"L Yi","year":"2004","unstructured":"Yi, L. et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 78, 11334. https:\/\/doi.org\/10.1128\/JVI.78.20.11334-11339.2004 (2004).","journal-title":"J. Virol."},{"key":"18676_CR53","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/cbdv.200890045","volume":"5","author":"MR Loizzo","year":"2008","unstructured":"Loizzo, M. R. et al. Phytochemical analysis and in vitro antiviral activities of the essential oils of seven lebanon species. Chem. Biodivers. 5, 461\u2013470. https:\/\/doi.org\/10.1002\/cbdv.200890045 (2008).","journal-title":"Chem. Biodivers."},{"key":"18676_CR54","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1089\/acm.2004.10.1041","volume":"10","author":"J Liu","year":"2004","unstructured":"Liu, J., Manheimer, E., Shi, Y. & Gluud, C. Chinese herbal medicine for severe acute respiratory syndrome: A systematic review and meta-analysis. J. Altern. Complement. Med. 10, 1041\u20131051. https:\/\/doi.org\/10.1089\/acm.2004.10.1041 (2004).","journal-title":"J. Altern. Complement. Med."},{"key":"18676_CR55","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1021\/acsomega.0c00772","volume":"5","author":"BTP Thuy","year":"2020","unstructured":"Thuy, B. T. P. et al. Investigation into SARS-CoV-2 resistance of compounds in garlic essential Oil. ACS Omega 5, 8312\u20138320. https:\/\/doi.org\/10.1021\/acsomega.0c00772 (2020).","journal-title":"ACS Omega"},{"key":"18676_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/plants9060800","author":"MN Boukhatem","year":"2020","unstructured":"Boukhatem, M. N. & Setzer, W. N. Aromatic herbs, medicinal plant-derived essential oils, and phytochemical extracts as potential therapies for coronaviruses: Future perspectives. Plants https:\/\/doi.org\/10.3390\/plants9060800 (2020).","journal-title":"Plants"},{"key":"18676_CR57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12985-020-01401-2","volume":"17","author":"J Signer","year":"2020","unstructured":"Signer, J. et al. In vitro virucidal activity of Echinaforce\u00ae, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2. Virol. J. 17, 136. https:\/\/doi.org\/10.1186\/s12985-020-01401-2 (2020).","journal-title":"Virol. J."},{"key":"18676_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.893634","author":"S \u0106avar Zeljkovi\u0107","year":"2022","unstructured":"\u0106avar Zeljkovi\u0107, S., Schadich, E., D\u017eub\u00e1k, P., Hajd\u00fach, M. & Tarkowski, P. Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.893634 (2022).","journal-title":"Front. Pharmacol."},{"key":"18676_CR59","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.07.20180448","author":"NA Mohamed","year":"2020","unstructured":"Mohamed, N. A. et al. Early viral clearance among covid-19 patients when gargling with povidone-iodine and essential oils: a pilot clinical trial. medRxiv https:\/\/doi.org\/10.1101\/2020.09.07.20180448 (2020).","journal-title":"medRxiv"},{"key":"18676_CR60","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3201\/eid2607.200915","volume":"26","author":"A Kratzel","year":"2020","unstructured":"Kratzel, A. et al. Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols. Emerg. Infect. Dis. J. 26, 1592. https:\/\/doi.org\/10.3201\/eid2607.200915 (2020).","journal-title":"Emerg. Infect. Dis. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18676-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18676-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18676-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:35:19Z","timestamp":1669361719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18676-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18676"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18676-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"15 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14230"}}